Research Article
Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study
Table 4
Comparison of the Cooperative Ocular Oncology Group (COOG) [
2] and CLEAR studies.
| ā | COOG [2] | CLEAR | Class 1 | Class 2 | Class 1 | Class 2 |
| n (%) | 276 (61.9%) | 170 (38.1%) | 37 (52.8%) | 33 (47.2%) | Age (yrs) (median, mean) | 59, 59.6 | 65.9, 65.3 | 62, 60.5 | 63, 62.7 | Tumor diameter (mm) (median, mean) | 12.0, 12.1 | 14.0, 13.9 | 12.7, 12.8 | 16, 15.64 | Tumor thickness (mm) (median, mean) | 5.0, 5.7 | 6.2, 7.0 | 5, 5.89 | 7.1, 7.02 | Ciliary body involvement | 61 (22.7%) | 72 (43.6%) | 15 (41%) | 12 (36%) | 3-year metastasis-free survival | 97% | 50% | 100% | 63% |
|
|
The CLEAR study is a registry and therefore may not be entirely reflective of the general population of UM patients.
|